323 related articles for article (PubMed ID: 27799472)
1. Empower multiplex cell and tissue-specific CRISPR-mediated gene manipulation with self-cleaving ribozymes and tRNA.
Xu L; Zhao L; Gao Y; Xu J; Han R
Nucleic Acids Res; 2017 Mar; 45(5):e28. PubMed ID: 27799472
[TBL] [Abstract][Full Text] [Related]
2. In Planta Processing of the SpCas9-gRNA Complex.
Mikami M; Toki S; Endo M
Plant Cell Physiol; 2017 Nov; 58(11):1857-1867. PubMed ID: 29040704
[TBL] [Abstract][Full Text] [Related]
3. Development of a gRNA Expression and Processing Platform for Efficient CRISPR-Cas9-Based Gene Editing and Gene Silencing in Candida tropicalis.
Li Y; Zhang L; Yang H; Xia Y; Liu L; Chen X; Shen W
Microbiol Spectr; 2022 Jun; 10(3):e0005922. PubMed ID: 35543560
[TBL] [Abstract][Full Text] [Related]
4. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
Berkhout B; Gao Z; Herrera-Carrillo E
Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Mediated Activation of Endogenous Gene Expression in the Postnatal Heart.
Schoger E; Carroll KJ; Iyer LM; McAnally JR; Tan W; Liu N; Noack C; Shomroni O; Salinas G; Groß J; Herzog N; Doroudgar S; Bassel-Duby R; Zimmermann WH; Zelarayán LC
Circ Res; 2020 Jan; 126(1):6-24. PubMed ID: 31730408
[TBL] [Abstract][Full Text] [Related]
6. Harnessing tRNA for Processing Ability and Promoter Activity.
Knapp DJHF; Fulga TA
Methods Mol Biol; 2021; 2162():89-114. PubMed ID: 32926380
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
[TBL] [Abstract][Full Text] [Related]
8. Self-cleaving ribozymes enable the production of guide RNAs from unlimited choices of promoters for CRISPR/Cas9 mediated genome editing.
He Y; Zhang T; Yang N; Xu M; Yan L; Wang L; Wang R; Zhao Y
J Genet Genomics; 2017 Sep; 44(9):469-472. PubMed ID: 28958488
[No Abstract] [Full Text] [Related]
9. Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system.
Xie K; Minkenberg B; Yang Y
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3570-5. PubMed ID: 25733849
[TBL] [Abstract][Full Text] [Related]
10. Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays.
Kurata M; Wolf NK; Lahr WS; Weg MT; Kluesner MG; Lee S; Hui K; Shiraiwa M; Webber BR; Moriarity BS
PLoS One; 2018; 13(9):e0198714. PubMed ID: 30222773
[TBL] [Abstract][Full Text] [Related]
11. A Multiplexed CRISPR/Cas9 Editing System Based on the Endogenous tRNA Processing.
Xie K; Yang Y
Methods Mol Biol; 2019; 1917():63-73. PubMed ID: 30610628
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 with single guide RNA expression driven by small tRNA promoters showed reduced editing efficiency compared to a U6 promoter.
Wei Y; Qiu Y; Chen Y; Liu G; Zhang Y; Xu L; Ding Q
RNA; 2017 Jan; 23(1):1-5. PubMed ID: 27742910
[TBL] [Abstract][Full Text] [Related]
13. Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation.
Tang W; Hu JH; Liu DR
Nat Commun; 2017 Jun; 8():15939. PubMed ID: 28656978
[TBL] [Abstract][Full Text] [Related]
14. Polycistronic tRNA and CRISPR guide-RNA enables highly efficient multiplexed genome engineering in human cells.
Dong F; Xie K; Chen Y; Yang Y; Mao Y
Biochem Biophys Res Commun; 2017 Jan; 482(4):889-895. PubMed ID: 27890617
[TBL] [Abstract][Full Text] [Related]
15. Multiplex base- and prime-editing with drive-and-process CRISPR arrays.
Yuan Q; Gao X
Nat Commun; 2022 May; 13(1):2771. PubMed ID: 35589728
[TBL] [Abstract][Full Text] [Related]
16. Single transcript unit CRISPR 2.0 systems for robust Cas9 and Cas12a mediated plant genome editing.
Tang X; Ren Q; Yang L; Bao Y; Zhong Z; He Y; Liu S; Qi C; Liu B; Wang Y; Sretenovic S; Zhang Y; Zheng X; Zhang T; Qi Y; Zhang Y
Plant Biotechnol J; 2019 Jul; 17(7):1431-1445. PubMed ID: 30582653
[TBL] [Abstract][Full Text] [Related]
17. Efficient gene editing in a medaka (
Pan Q; Luo J; Jiang Y; Wang Z; Lu K; Chen T
J Zhejiang Univ Sci B; 2022 Jan; 23(1):74-83. PubMed ID: 35029089
[TBL] [Abstract][Full Text] [Related]
18. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
19. Self-cleaving guide RNAs enable pharmacological selection of precise gene editing events in vivo.
Tiyaboonchai A; Vonada A; Posey J; Pelz C; Wakefield L; Grompe M
Nat Commun; 2022 Nov; 13(1):7391. PubMed ID: 36450762
[TBL] [Abstract][Full Text] [Related]
20. Ribozyme Mediated gRNA Generation for In Vitro and In Vivo CRISPR/Cas9 Mutagenesis.
Lee RT; Ng AS; Ingham PW
PLoS One; 2016; 11(11):e0166020. PubMed ID: 27832146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
